- Home
- TCBK vs MDXG Comparison
TCBK vs MDXG Comparison
Compare TCBK & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBK
- MDXG
- Stock Information
- Founded
- TCBK 1975
- MDXG 2006
- Country
- TCBK United States
- MDXG United States
- Employees
- TCBK N/A
- MDXG N/A
- Industry
- TCBK Major Banks
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- TCBK Finance
- MDXG Health Care
- Exchange
- TCBK Nasdaq
- MDXG Nasdaq
- Market Cap
- TCBK 1.4B
- MDXG 1.1B
- IPO Year
- TCBK N/A
- MDXG N/A
- Fundamental
- Price
- TCBK $44.45
- MDXG $9.10
- Analyst Decision
- TCBK Buy
- MDXG Strong Buy
- Analyst Count
- TCBK 6
- MDXG 5
- Target Price
- TCBK $48.20
- MDXG $12.00
- AVG Volume (30 Days)
- TCBK 138.1K
- MDXG 814.8K
- Earning Date
- TCBK 01-23-2025
- MDXG 10-30-2024
- Dividend Yield
- TCBK 2.97%
- MDXG N/A
- EPS Growth
- TCBK N/A
- MDXG N/A
- EPS
- TCBK 3.36
- MDXG 0.52
- Revenue
- TCBK $387,200,000.00
- MDXG $342,804,000.00
- Revenue This Year
- TCBK N/A
- MDXG $9.56
- Revenue Next Year
- TCBK $3.74
- MDXG $9.19
- P/E Ratio
- TCBK $13.23
- MDXG $18.08
- Revenue Growth
- TCBK N/A
- MDXG 10.93
- 52 Week Low
- TCBK $31.73
- MDXG $5.47
- 52 Week High
- TCBK $51.06
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- TCBK 37.16
- MDXG 53.38
- Support Level
- TCBK $43.62
- MDXG $9.07
- Resistance Level
- TCBK $49.71
- MDXG $9.60
- Average True Range (ATR)
- TCBK 1.32
- MDXG 0.32
- MACD
- TCBK -0.66
- MDXG -0.16
- Stochastic Oscillator
- TCBK 15.43
- MDXG 14.05
About TCBK TriCo Bancshares
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of Treasury Management Services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.